Agios Pharmaceuticals (AGIO) is down -14.4%, or -$5.86 to $34.75.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AGIO:
- Agios Pharmaceuticals provides update on U.S. PDUFA goal date for PYRUKYND
- Positive Outlook for Agios Pharma Despite Recent Patient Deaths Unrelated to Pyrukynd Treatment
- Agios Pharmaceuticals reports Pyrukynd approval by Saudi Food and Drug Authority
- Agios Pharma’s PYRUKYND Approved by Saudi Authority
- Leerink says Agios pressure related to deaths listed in FAERS database